Trevi's Haduvio reduces chronic cough by 57% vs placebo in Phase 2a trial, surpassing expectations. Stock rises 40%.

Arrowhead Pharmaceuticals on Monday shared new open-label data in about a dozen patients for a program designed to improve ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Dr Minit Shah, et al., Genomic profiling of driver gene alterations in pa- tients with non-small cell lung cancer, patterns of treatment and impact on survival outcomes – A single center ...